Company overview
EndoQuest Robotics develops a flexible endoluminal surgical platform that enables incisionless procedures via natural orifices—reducing pain, accelerating recovery, and eliminating scarring. Unlike traditional rigid laparoscopic robots, the system navigates the body’s natural pathways, supporting applications in gastroenterology, urology, and other minimally invasive fields. It includes a steerable robotic arm, multi-channel access, intuitive controls that shorten the learning curve for surgeons, and an integrated 3D visualization interface for real-time guidance. The platform is designed to fit seamlessly into hospital workflows, with ongoing development focused on expanding supported procedures and providing robust training and clinical validation.
The company uses a hybrid Hardware-as-a-Service (HaaS) model. Surgical centers purchase the robotic platform as a capital expenditure, but also engage in ongoing service and support contracts that provide maintenance, updates, and access to training programs. For healthcare providers seeking financial flexibility, EndoQuest offers structured leasing options with monthly payments, reducing upfront costs and enabling wider adoption. This hybrid model ensures that hospitals can access cutting-edge robotic systems while benefiting from continuous support and evolving capabilities.
Customers and target markets
- Brigham and Women’s Hospital
- Mayo Clinic
- Cleveland Clinic
- AdventHealth (clinical trials)
Company metrics
- Headquarters:
- Houston, Texas
- Company size:
- 51-200
- Founded:
- 2017
- Industries:
